Skip to main content
  • EN
  • FI
  • SV
Login

Main navigation

  • About FinnGen
    • Summary & Goals
      • Goals
      • FinnGen 1-2
      • FinnGen 3 (2023-2027)
    • Consortium
      • Partners
      • Funding
      • Governance
      • Steering Committee Members
      • Scientific Committee Members
      • Teams
      • Collaboration
    • Impact
      • National Impact
      • National Research Network
      • Open Science
      • Research Highlights
    • Why Finland?
      • Biobank Network
      • Legislative Review
      • National Registries
      • Population Genetic History
      • Industry partners
    • Mediabank
  • For Researchers
    • Research Activities
      • Core Analyses
      • Disease Task Forces
      • Expansion Areas
      • Global Initiatives
    • Cohort and Data
      • Register Data
      • Basic Characteristics
      • Clinical Endpoints
      • Genetic Data
      • Laboratory Values
      • Other Phenotype Data
      • Recruitment
      • Other Biological Data
      • Data Available
    • Accessing Data, Results & Tools
      • Access results
      • Computing environment
      • How we collaborate
      • Partner researchers
      • Public data releases
      • Tools
    • Publications
    • Researcher FAQ
  • For Participants
    • Participation
      • Study Participants
      • Biobanks' Role in FinnGen
      • Biobank Contact Information
      • Recall Studies
      • Questions and answers
    • Data Protection and Security
      • Data Protection
      • Data Security
      • Sample & Data Flow
      • Data Protection Statement
    • Significance
      • Videos
  • News
  • EN
  • FI
  • SV

Links

  • PheWeb
  • Risteys
  • Meta-analysis Pheweb (FG-MVP-UKBB)
  • FinnGen handbook
  • Meta-analysis Pheweb (FG-UKBB)
  • Coding variant browser
  • Endpoint Browser
  • FinnGen GITHUB
  • LAVAA volcano plot
  • Multiple Manhattan Plot
  • Variant Cluster Corrector
  • Variant Cluster Call Corrector
Breadcrumb
  1. Home

Serum Albumin and Circulating Metabolites and Risk of Venous Thromboembolism: A Two-Sample Mendelian Randomization Study

Submitted by Frida Mäkelä on Mon, 08/29/2022 - 15:23
  • Read more about Serum Albumin and Circulating Metabolites and Risk of Venous Thromboembolism: A Two-Sample Mendelian Randomization Study

Commonly occurring genetic polymorphisms with a major impact on the risk of nonsyndromic strabismus: replication in a sample from Finland

Submitted by Frida Mäkelä on Mon, 08/29/2022 - 15:20
  • Read more about Commonly occurring genetic polymorphisms with a major impact on the risk of nonsyndromic strabismus: replication in a sample from Finland

Leveraging Northern European population history: novel low-frequency variants for polycystic ovary syndrome

Submitted by Frida Mäkelä on Mon, 08/29/2022 - 15:15
  • Read more about Leveraging Northern European population history: novel low-frequency variants for polycystic ovary syndrome

Risk of lower respiratory tract infections: a genome-wide association study with Mendelian randomization analysis in three independent European populations

Submitted by Frida Mäkelä on Mon, 08/29/2022 - 15:01
  • Read more about Risk of lower respiratory tract infections: a genome-wide association study with Mendelian randomization analysis in three independent European populations

Depression and Inflammatory Bowel Disease: A Bidirectional Two-sample Mendelian Randomization Study

Submitted by Frida Mäkelä on Mon, 08/29/2022 - 14:58
  • Read more about Depression and Inflammatory Bowel Disease: A Bidirectional Two-sample Mendelian Randomization Study

A trans-omic Mendelian randomization study of parental lifespan uncovers novel aging biology and therapeutic candidates for chronic diseases

Submitted by Frida Mäkelä on Mon, 08/29/2022 - 14:56
  • Read more about A trans-omic Mendelian randomization study of parental lifespan uncovers novel aging biology and therapeutic candidates for chronic diseases

Coffee and Caffeine Consumption and Risk of Kidney Stones: A Mendelian Randomization Study

Submitted by Frida Mäkelä on Mon, 08/29/2022 - 14:54
  • Read more about Coffee and Caffeine Consumption and Risk of Kidney Stones: A Mendelian Randomization Study

Genetic Profile of Endotoxemia Reveals an Association With Thromboembolism and Stroke

Submitted by Frida Mäkelä on Mon, 08/29/2022 - 14:52
  • Read more about Genetic Profile of Endotoxemia Reveals an Association With Thromboembolism and Stroke

Cardiometabolic, Lifestyle, and Nutritional Factors in Relation to Varicose Veins: A Mendelian Randomization Study

Submitted by Frida Mäkelä on Mon, 08/29/2022 - 14:50
  • Read more about Cardiometabolic, Lifestyle, and Nutritional Factors in Relation to Varicose Veins: A Mendelian Randomization Study

Genome-wide analysis identifies gallstone-susceptibility loci including genes regulating gastrointestinal motility

Submitted by Frida Mäkelä on Mon, 08/29/2022 - 14:48
  • Read more about Genome-wide analysis identifies gallstone-susceptibility loci including genes regulating gastrointestinal motility

Pagination

  • First page « First
  • Previous page ‹ Previous
  • …
  • Page 495
  • Page 496
  • Page 497
  • Page 498
  • Current page 499
  • Page 500
  • Page 501
  • Page 502
  • Page 503
  • …
  • Next page Next ›
  • Last page Last »
Subscribe to

Contact us

Contact person
finngen-info@helsinki.fi
Follow us on Bluesky
@finngen.bsky.social
Follow us on LinkedIn
https://www.linkedin.com/company/finngen/

Lead organisations

The University of Helsinki is the organization responsible for the FinnGen research project. The Finnish consortium partners include all Finnish public biobanks and their background organisations, so the project covers the whole of Finland. All partners are listed on this page.

About the website

Accessibility statement